A randomized, phase II trial of cetuximab with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer.
Saved in:
| Title: | A randomized, phase II trial of cetuximab with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer. |
|---|---|
| Authors: | Jimeno, A.1, Shirai, K.2, Choi, M.3, Laskin, J.4, Kochenderfer, M.5, Spira, A.6,7, Cline-Burkhardt, V.8, Winquist, E.9, Hausman, D.10, Walker, L.10, Cohen, R. B.11 |
| Source: | Annals of Oncology. Mar2015, Vol. 26 Issue 3, p556-561. 6p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 101371464 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A randomized, phase II trial of cetuximab with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Jimeno%2C+A%2E%22">Jimeno, A.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Shirai%2C+K%2E%22">Shirai, K.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Choi%2C+M%2E%22">Choi, M.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Laskin%2C+J%2E%22">Laskin, J.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Kochenderfer%2C+M%2E%22">Kochenderfer, M.</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Spira%2C+A%2E%22">Spira, A.</searchLink><relatesTo>6,7</relatesTo><br /><searchLink fieldCode="AR" term="%22Cline-Burkhardt%2C+V%2E%22">Cline-Burkhardt, V.</searchLink><relatesTo>8</relatesTo><br /><searchLink fieldCode="AR" term="%22Winquist%2C+E%2E%22">Winquist, E.</searchLink><relatesTo>9</relatesTo><br /><searchLink fieldCode="AR" term="%22Hausman%2C+D%2E%22">Hausman, D.</searchLink><relatesTo>10</relatesTo><br /><searchLink fieldCode="AR" term="%22Walker%2C+L%2E%22">Walker, L.</searchLink><relatesTo>10</relatesTo><br /><searchLink fieldCode="AR" term="%22Cohen%2C+R%2E+B%2E%22">Cohen, R. B.</searchLink><relatesTo>11</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. Mar2015, Vol. 26 Issue 3, p556-561. 6p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=101371464 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/annonc/mdu574 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 6 StartPage: 556 Titles: – TitleFull: A randomized, phase II trial of cetuximab with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jimeno, A. – PersonEntity: Name: NameFull: Shirai, K. – PersonEntity: Name: NameFull: Choi, M. – PersonEntity: Name: NameFull: Laskin, J. – PersonEntity: Name: NameFull: Kochenderfer, M. – PersonEntity: Name: NameFull: Spira, A. – PersonEntity: Name: NameFull: Cline-Burkhardt, V. – PersonEntity: Name: NameFull: Winquist, E. – PersonEntity: Name: NameFull: Hausman, D. – PersonEntity: Name: NameFull: Walker, L. – PersonEntity: Name: NameFull: Cohen, R. B. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: Mar2015 Type: published Y: 2015 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 26 – Type: issue Value: 3 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |